Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate Aplastic Anemia”

48 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 48 results

Not applicableUnknownNCT00295997
What this trial is testing

Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic Anemia

Who this might be right for
Chronic Myeloproliferative DisordersKidney CancerLeukemia+4 more
University of California, San Francisco 35
Testing effectiveness (Phase 2)Study completedNCT00229619
What this trial is testing

Rituximab to Treat Moderate Aplastic Anemia, Pure Red Cell Aplasia, or Diamond Blackfan Anemia

Who this might be right for
Anemia, AplasticRed-Cell Aplasia, PureAnemia, Diamond-Blackfan
National Heart, Lung, and Blood Institute (NHLBI) 11
Large-scale testing (Phase 3)Not Yet RecruitingNCT07548671
What this trial is testing

Enarodustat + CsA vs CsA in Newly Diagnosed TD-NSAA

Who this might be right for
Transfusion-dependent Non-severe Aplastic Anemia
Peking Union Medical College Hospital 90
Testing effectiveness (Phase 2)WithdrawnNCT00816413
What this trial is testing

Donor Stem Cell Transplant, Pentostatin, and Total-Body Irradiation in Treating Patients With Hematological Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+2 more
University of Nebraska
Not applicableStudy completedNCT00053157
What this trial is testing

Sargramostim in Reducing Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplantation for Hematologic Cancer or Aplastic Anemia

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+3 more
Roswell Park Cancer Institute 10
Large-scale testing (Phase 3)WithdrawnNCT05018936
What this trial is testing

Efficacy and Safety of Hetrombopag in Non-severe Aplastic Anemia

Who this might be right for
Aplastic AnemiaDrug Effect
Peking Union Medical College Hospital
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07558434
What this trial is testing

CsA+EPAG/HPAG+Romiplostim N01 in Newly-diagnosed SAA/TD-NSAA

Who this might be right for
Severe Aplastic Anemia (SAA)Transfusion-dependent Non-severe Aplastic Anemia
Peking Union Medical College Hospital 43
Not applicableLooking for participantsNCT01137643
What this trial is testing

Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+5 more
UNC Lineberger Comprehensive Cancer Center 15,000
Testing effectiveness (Phase 2)Study completedNCT05399732
What this trial is testing

Efficacy and Safety in Transfusion Independent Non-severe Aplastic Anemia

Who this might be right for
Aplastic Anemia
Bing Han 58
Testing effectiveness (Phase 2)UnknownNCT06004752
What this trial is testing

Efficacy and Safety of CsA+AVA in the Treatment of NSAA in the Elderly

Who this might be right for
Aplastic Anemia
Peking Union Medical College Hospital 30
Testing effectiveness (Phase 2)Study completedNCT02148133
What this trial is testing

Assess the Safety and Efficacy of Eltrombopag in Japanese Subjects With Refractory, Moderate or More Severe Aplastic Anemia

Who this might be right for
Cytopaenia
Novartis Pharmaceuticals 21
Not applicableStudy completedNCT00521430
What this trial is testing

Donor Stem Cell Transplant After Conditioning Therapy in Treating Patients With Hematologic Cancer, Recurrent or Metastatic Solid Tumor, or Other Disease

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+3 more
Asan Medical Center 30
Testing effectiveness (Phase 2)WithdrawnNCT07523009
What this trial is testing

CsA+EPAG/HPAG+Romiplostim N01 in the Treatment of Newly-diagnosed SAA/TD-NSAA

Who this might be right for
Severe Aplastic Anemia (SAA)Transfusion-dependent Non-severe Aplastic Anemia
Peking Union Medical College Hospital
Post-approval studies (Phase 4)UnknownNCT01995331
What this trial is testing

Moderate-dose Cyclophosphamide for Childhood Acquired Aplastic Anemia

Who this might be right for
Aplastic Anemia
Xiaofan Zhu 30
Not applicableStudy completedNCT00964821
What this trial is testing

Flu Vaccine in Preventing Influenza Infection in Healthy Volunteers and in Patients Who Have Undergone Stem Cell Transplant

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
City of Hope Medical Center 459
Early research (Phase 1)Ended earlyNCT01267643
What this trial is testing

Alefacept in Patients With Relapsed/Refractory Aplastic Anemia

Who this might be right for
Aplastic Anemia
The Cleveland Clinic 4
Testing effectiveness (Phase 2)Study completedNCT00053989
What this trial is testing

NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/Disorders

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+5 more
Roswell Park Cancer Institute 41
Testing effectiveness (Phase 2)Study completedNCT02404025
What this trial is testing

Eltrombopag in Combination With Rabbit Anti-thymocyte Globulin/Cyclosporine A in Naive Aplastic Anemia (AA) Subjects

Who this might be right for
Aplastic Anemia
Novartis Pharmaceuticals 10
Post-approval studies (Phase 4)UnknownNCT06426043
What this trial is testing

A Prospective Study on the Treatment of Recurrent/Refractory/Intolerable NSAA With Lusutrombopag

Who this might be right for
Aplastic Anemia
Peking Union Medical College Hospital 40
Testing effectiveness (Phase 2)Study completedNCT01529827
What this trial is testing

Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+75 more
Roswell Park Cancer Institute 94
Load More Results